Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: A randomized controlled trial
- 30 June 2011
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 64 (6), 1074-1084
- https://doi.org/10.1016/j.jaad.2010.04.027
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Systemic therapeutic options for severe atopic dermatitisJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2009
- Efficacy and safety of long‐term treatment with cyclosporin A for atopic dermatitisJournal of the European Academy of Dermatology and Venereology, 2006
- Treatment of atopic dermatitis with mycophenolate mofetilBritish Journal of Dermatology, 2000
- Treatment of atopic eczema with oral mycophenolate mofetilBritish Journal of Dermatology, 2000
- Mechanism of Action of Mycophenolate MofetilTherapeutic Drug Monitoring, 1995
- Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapyBritish Journal of Dermatology, 1995
- Cyclosporin in atopic dermatitis: a multicentre placebo-controlled studyBritish Journal of Dermatology, 1994
- Maintenance treatment with cyclosporin in atopic eczemaBritish Journal of Dermatology, 1994
- Identification of calcineurin as a key signalling enzyme in T-lymphocyte activationNature, 1992
- Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitisThe Lancet, 1991